|
US8992984B1
(en)
|
2009-10-21 |
2015-03-31 |
Stc.Unm |
Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
AU2012249474A1
(en)
|
2011-04-28 |
2013-11-07 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
|
BR112014001346A8
(pt)
|
2011-07-19 |
2018-05-08 |
Stc Unm |
composto nanotransportador, método, composto farmacêutico e uso de um composto
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9273305B1
(en)
|
2012-04-25 |
2016-03-01 |
Sandia Corporation |
Cell-based composite materials with programmed structures and functions
|
|
ES2821528T3
(es)
|
2012-11-14 |
2021-04-26 |
Grace W R & Co |
Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
|
|
SG11201503750YA
(en)
*
|
2012-11-16 |
2015-06-29 |
Univ Cardiff |
Process for preparing nucleoside prodrugs
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
EP4378461A3
(en)
|
2013-03-05 |
2024-09-11 |
The Regents of University of California |
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014201276A1
(en)
|
2013-06-12 |
2014-12-18 |
The Methodist Hospital |
Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
|
|
WO2015013352A2
(en)
*
|
2013-07-25 |
2015-01-29 |
Patel Hasmukh B |
Nucleoside phosphoramidates and phosphoramidites
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015042268A1
(en)
*
|
2013-09-18 |
2015-03-26 |
Stc.Unm |
Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo
|
|
EP3046543A1
(en)
|
2013-09-18 |
2016-07-27 |
Stc.Unm |
Torroidal mesoporous silica nanoparticles (tmsnps) and related protocells
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
|
US9474720B2
(en)
|
2013-11-04 |
2016-10-25 |
BioPharmX, Inc. |
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
|
CA2943109A1
(en)
*
|
2014-01-17 |
2015-07-23 |
Nariyoshi Shinomiya |
Molecule associated with onset of gout, and method and kit for evaluating diathesis of uric acid-related disease and inflammation-related diseases, and inspection object and drug
|
|
EP3169693B1
(en)
|
2014-07-16 |
2022-03-09 |
ModernaTX, Inc. |
Chimeric polynucleotides
|
|
EP3173074A4
(en)
|
2014-07-22 |
2018-03-07 |
Lemonex Inc. |
Composition for delivering bioactive material or protein, and use thereof
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
US20160090603A1
(en)
*
|
2014-09-30 |
2016-03-31 |
Sandia Corporation |
Delivery platforms for the domestication of algae and plants
|
|
ES2977259T3
(es)
|
2014-11-05 |
2024-08-21 |
Cartesian Therapeutics Inc |
Métodos y composiciones relacionadas con nanovehículos sintéticos con rapamicina en un estado sobresaturado estable
|
|
US20180110831A1
(en)
*
|
2015-03-09 |
2018-04-26 |
Stc.Unm |
Cd 47 containing porous nanoparticle supported lipid bilayers (protocells) field of the invention
|
|
AU2016252393A1
(en)
*
|
2015-04-24 |
2017-11-09 |
Colgate-Palmolive Company |
Porous protein particles as carriers for actives
|
|
CN114533898B
(zh)
*
|
2015-07-09 |
2025-07-01 |
加利福尼亚大学董事会 |
融合脂质体包被的多孔硅纳米颗粒
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
EP3324979B1
(en)
|
2015-07-21 |
2022-10-12 |
ModernaTX, Inc. |
Infectious disease vaccines
|
|
US10624949B1
(en)
|
2015-07-27 |
2020-04-21 |
National Technology & Engineering Solutions Of Sandia, Llc |
Methods for treating diseases related to the wnt pathway
|
|
EP4286012A3
(en)
|
2015-09-17 |
2024-05-29 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN108289966A
(zh)
*
|
2015-09-24 |
2018-07-17 |
北卡罗来纳-查佩尔山大学 |
用于减少转移的方法和组合物
|
|
CN105174211B
(zh)
*
|
2015-10-12 |
2017-02-01 |
海南大学 |
一种具有表面增强拉曼活性银基复合纳米材料的制备方法及其所得产品和应用
|
|
CA3002912A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
TW201729835A
(zh)
|
2015-10-22 |
2017-09-01 |
現代公司 |
呼吸道病毒疫苗
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
US20180289792A1
(en)
|
2015-10-22 |
2018-10-11 |
ModernaTX. Inc. |
Sexually transmitted disease vaccines
|
|
JP6667896B2
(ja)
*
|
2015-11-06 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
リボ核酸固定化担体及びそれを用いたリボ核酸の分離回収方法
|
|
HRP20220652T1
(hr)
|
2015-12-10 |
2022-06-24 |
Modernatx, Inc. |
Pripravci i postupci unosa terapijskih sredstava
|
|
HUE057877T2
(hu)
|
2015-12-22 |
2022-06-28 |
Modernatx Inc |
Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására
|
|
RS63135B1
(sr)
|
2015-12-23 |
2022-05-31 |
Modernatx Inc |
Postupci upotrebe polinukleotida koji kodiraju ox40 ligand
|
|
CN108601746B
(zh)
*
|
2016-01-08 |
2024-09-13 |
加利福尼亚大学董事会 |
用于运载物递送的具有脂质双层包衣的中孔二氧化硅纳米颗粒
|
|
US11672866B2
(en)
|
2016-01-08 |
2023-06-13 |
Paul N. DURFEE |
Osteotropic nanoparticles for prevention or treatment of bone metastases
|
|
US20190241658A1
(en)
|
2016-01-10 |
2019-08-08 |
Modernatx, Inc. |
Therapeutic mRNAs encoding anti CTLA-4 antibodies
|
|
EP3442540A4
(en)
*
|
2016-04-14 |
2019-12-18 |
Spinnaker Biosciences Inc. |
POROUS SILICON MATERIALS WITH A METAL SILICATE FOR DELIVERING THERAPEUTIC ACTIVE SUBSTANCES
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
CN115404196A
(zh)
*
|
2016-07-13 |
2022-11-29 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
EP3269444A1
(en)
*
|
2016-07-14 |
2018-01-17 |
Base4 Innovation Ltd |
Method of identifying droplets in a stack and an associated sequencer
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018089851A2
(en)
|
2016-11-11 |
2018-05-17 |
Modernatx, Inc. |
Influenza vaccine
|
|
WO2018107088A2
(en)
|
2016-12-08 |
2018-06-14 |
Modernatx, Inc. |
Respiratory virus nucleic acid vaccines
|
|
LU100023B1
(en)
*
|
2017-01-20 |
2018-07-30 |
Luxembourg Inst Science & Tech List |
Nanocapsules and method for manufacturing thereof
|
|
CN106822916B
(zh)
*
|
2017-01-25 |
2020-02-28 |
浙江大学 |
一种pH敏感的纳米化Bcl-2选择性抑制剂的制备方法及产物和应用
|
|
ES2973040T3
(es)
|
2017-01-27 |
2024-06-18 |
Methodist Hospital |
Plataforma de estructura de núcleo/cáscara para inmunoterapia
|
|
KR20180091768A
(ko)
|
2017-02-06 |
2018-08-16 |
주식회사 레모넥스 |
생리활성물질 전달체
|
|
WO2018160865A1
(en)
|
2017-03-01 |
2018-09-07 |
Charles Jeffrey Brinker |
Active targeting of cells by monosized protocells
|
|
SMT202300097T1
(it)
|
2017-03-15 |
2023-05-12 |
Modernatx Inc |
Composto e composizioni per il rilascio intracellulare di agenti terapeutici
|
|
US11969506B2
(en)
|
2017-03-15 |
2024-04-30 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
US11752206B2
(en)
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
RESPIRATORY SYNCYTIAL VIRUS Vaccine
|
|
WO2018170245A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
US11045540B2
(en)
|
2017-03-15 |
2021-06-29 |
Modernatx, Inc. |
Varicella zoster virus (VZV) vaccine
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
US11786607B2
(en)
|
2017-06-15 |
2023-10-17 |
Modernatx, Inc. |
RNA formulations
|
|
US11007516B1
(en)
|
2017-06-19 |
2021-05-18 |
National Technology & Engineering Solutions Of Sandia, Llc |
Tunable metal-organic framework compositions and methods thereof
|
|
AU2018306411B2
(en)
*
|
2017-07-28 |
2022-03-31 |
Lemonex Inc. |
Pharmaceutical composition for preventing or treating liver cancer
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
WO2019050283A1
(ko)
*
|
2017-09-05 |
2019-03-14 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
KR102152348B1
(ko)
|
2017-09-05 |
2020-09-08 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
EP3681514A4
(en)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
RNA VACZINE AGAINST ZIKA VIRUS
|
|
US10933027B1
(en)
*
|
2017-09-25 |
2021-03-02 |
National Technology & Engineering Solutions Of Sandia, Llc |
Expanded pore particles and delivery methods thereof
|
|
CN107952076A
(zh)
*
|
2017-11-07 |
2018-04-24 |
徐州医科大学 |
一种多囊脂质体/多孔碳纳米复合物、制备方法及应用
|
|
US20200330616A1
(en)
*
|
2017-11-13 |
2020-10-22 |
POLITECNICO Dl TORINO |
Biomimetic non-immunogenic nanoassembly for the antitumor therapy
|
|
US11661599B1
(en)
|
2017-12-14 |
2023-05-30 |
National Technology & Engineering Solutions Of Sandia, Llc |
CRISPR-Cas based system for targeting single-stranded sequences
|
|
US12383499B2
(en)
|
2018-01-01 |
2025-08-12 |
The Regents Of The University Of California |
Scale up synthesis of silicasome nanocarriers
|
|
WO2019148101A1
(en)
|
2018-01-29 |
2019-08-01 |
Modernatx, Inc. |
Rsv rna vaccines
|
|
KR102017110B1
(ko)
*
|
2018-03-08 |
2019-09-02 |
한국화학연구원 |
구역화된 간소엽 모사체 및 이를 이용한 구역별 간독성 평가방법
|
|
AU2019255725A1
(en)
*
|
2018-04-18 |
2020-12-10 |
Ligandal, Inc. |
Methods and compositions for genome editing
|
|
WO2019204666A1
(en)
*
|
2018-04-18 |
2019-10-24 |
Oisin Biotechnologies, Inc. |
Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a target cell
|
|
JP7206297B2
(ja)
|
2018-05-18 |
2023-01-17 |
エフ．ホフマン－ラ ロシュ アーゲー |
大核酸の細胞内標的指向送達
|
|
US11045554B1
(en)
|
2018-06-22 |
2021-06-29 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid-coated particles for treating viral infections
|
|
AU2019317939A1
(en)
*
|
2018-08-06 |
2021-04-01 |
Lemonex Inc. |
Immunoreactant carrier
|
|
WO2020037530A1
(en)
*
|
2018-08-22 |
2020-02-27 |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. |
Crystalline form of compound and uses thereof in medicine
|
|
MA53650A
(fr)
|
2018-09-19 |
2021-07-28 |
Modernatx Inc |
Lipides peg et leurs utilisations
|
|
AU2019345067A1
(en)
|
2018-09-19 |
2021-04-08 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
US12263248B2
(en)
|
2018-09-19 |
2025-04-01 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN113271926A
(zh)
|
2018-09-20 |
2021-08-17 |
摩登纳特斯有限公司 |
脂质纳米颗粒的制备及其施用方法
|
|
WO2020068798A1
(en)
|
2018-09-24 |
2020-04-02 |
Guo Jimin |
Living mammalian cells modified with functional modular nanoparticles
|
|
KR20200051916A
(ko)
*
|
2018-11-05 |
2020-05-14 |
주식회사 메디포럼제약 |
고세렐린을 포함하는 실리카 하이드로겔 조성물
|
|
WO2020138907A2
(ko)
*
|
2018-12-24 |
2020-07-02 |
고려대학교 산학협력단 |
다양한 표면공정을 통한 3차원 신경세포체 형성 및 신경 돌기 생성이 가능한 구조체 제작
|
|
IT201900001009A1
(it)
|
2019-01-23 |
2020-07-23 |
Torino Politecnico |
Vettore nanoporoso biomimetico comprendente un inibitore diretto verso la forma nativa della proteina IDH2
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
WO2020171680A1
(ko)
*
|
2019-02-22 |
2020-08-27 |
주식회사 레모넥스 |
면역활성 또는 암의 예방 또는 치료용 의약 조성물
|
|
US12208164B2
(en)
|
2019-02-28 |
2025-01-28 |
Unm Rainforest Innovations |
Modular metal-organic polyhedra superassembly compositions
|
|
EP3938379A4
(en)
|
2019-03-15 |
2023-02-22 |
ModernaTX, Inc. |
Hiv rna vaccines
|
|
GB201904334D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
Carrier system for preparing herbaceous extracts
|
|
GB201904336D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
GB201904337D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
EP3714879A1
(en)
*
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|
|
WO2020200472A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Biontech Rna Pharmaceuticals Gmbh |
Preparation and storage of liposomal rna formulations suitable for therapy
|
|
US12377118B2
(en)
*
|
2019-08-09 |
2025-08-05 |
Case Western Reserve University |
Nanoparticle constructs for systemic co-delivery of anti-tumor agents
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
BR112022004936A2
(pt)
|
2019-09-19 |
2022-06-14 |
Modernatx Inc |
Compostos lipídicos contendo carbonato e composições para distribuição intracelular de agentes terapêuticos
|
|
AU2021224588B2
(en)
|
2020-02-18 |
2024-07-18 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
AU2021236234A1
(en)
|
2020-03-11 |
2022-10-06 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
|
US20230133587A1
(en)
*
|
2020-03-26 |
2023-05-04 |
Chinese Institute For Brain Research, Beijing |
Amino Acid Mediated Gene Delivery and Its Uses
|
|
US12605395B2
(en)
|
2020-04-01 |
2026-04-21 |
University Of Cincinnati |
Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy
|
|
US11433121B1
(en)
*
|
2020-04-03 |
2022-09-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid composition for the delivery of therapeutic cargos
|
|
CN113713115B
(zh)
*
|
2020-05-22 |
2023-11-24 |
青岛科技大学 |
一种采用碳多孔材料构建抗癌载药系统的方法
|
|
GB2600704A
(en)
*
|
2020-11-04 |
2022-05-11 |
Sumitomo Chemical Co |
Nanoparticle
|
|
WO2022115075A1
(en)
*
|
2020-11-30 |
2022-06-02 |
Ege Üni̇versi̇tesi̇ |
Targeted nanoparticles carrying dual drugs in the treatment of melanoma
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112870387B
(zh)
*
|
2021-02-26 |
2023-08-29 |
中山大学孙逸仙纪念医院 |
一种磁性纳米药物载体及其制备方法和应用
|
|
WO2022192674A1
(en)
*
|
2021-03-11 |
2022-09-15 |
The Trustees Of The University Of Pennsylvania |
Targeted therapeutic lipid nanoparticles and methods of use
|
|
CN113149023B
(zh)
*
|
2021-03-11 |
2023-05-02 |
昆明理工大学 |
一种介孔二氧化硅纳米颗粒经皮递送低共熔体系制备方法
|
|
EP4323362B1
(en)
|
2021-04-16 |
2025-05-07 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
CN113082226B
(zh)
*
|
2021-04-27 |
2023-12-15 |
山东中医药大学 |
一种载药纳米笼的制备方法与其靶向循环肿瘤细胞释放雷公藤甲素的应用
|
|
AU2022328698B2
(en)
|
2021-08-18 |
2025-02-20 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
CN113735350B
(zh)
*
|
2021-09-23 |
2023-01-24 |
深圳市水务规划设计院股份有限公司 |
一种黑臭水体处理工艺及其实验装置
|
|
CN117500908B
(zh)
*
|
2021-10-13 |
2025-08-22 |
坦佩雷大学基金会 |
一种细胞培养系统
|
|
CN114129718B
(zh)
*
|
2021-10-19 |
2024-05-03 |
华东师范大学 |
一种用于体内自组装car-t的纳米递送系统及其制备方法和应用
|
|
WO2023161350A1
(en)
|
2022-02-24 |
2023-08-31 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
US12145890B2
(en)
|
2022-12-16 |
2024-11-19 |
Raytheon Company |
Coated (core-shell) nanoparticles for nanocomposite optical ceramics
|
|
CN116327975A
(zh)
*
|
2022-12-20 |
2023-06-27 |
中国科学院基础医学与肿瘤研究所(筹) |
一种醋酸棉酚硅脂体及其制备方法和用途
|
|
CN116327985B
(zh)
*
|
2023-02-21 |
2024-09-27 |
武汉工程大学 |
一种具有靶向超声造影成像功能的空心囊泡载药递送系统及其制备方法与应用
|
|
WO2024237645A1
(ko)
*
|
2023-05-15 |
2024-11-21 |
주식회사 엠피오스 |
소수성 약물의 서방출용 실리카 기반 나노입자, 이의 제조방법 및 이를 포함하는 경피 약물투여시스템
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|